Table 4 The number of cases and evaluation matrices of segmentation results for clinical application in each category
Output categories | FCM combined with anatomical landmark data | FCM | ||
|---|---|---|---|---|
Training cohort | Testing cohort | All data | All data | |
Output I | ||||
 No. cases | 359 (81.41%) | 87 (77.68%) | 446 (80.65%) | 349 (63.11%) |
 %DSC | 91.30 ± 3.05 | 91.70 ± 2.55 |  |  |
 %JC | 84.13 ± 5.04 | 84.78 ± 4.30 |  |  |
 H (mm) | 15.75 ± 9.66 | 15.38 ± 9.25 |  |  |
 %FP | 8.83 ± 6.96 | 6.82 ± 5.33 |  |  |
 %FN-Type I | 8.47 ± 7.20 | 10.02 ± 6.98 |  |  |
 %FN-Type II | 0.00 | 0.00 |  |  |
Output II | ||||
 No. cases | 51 (11.56%) | 12 (10.71%) | 63 (11.39%) | 150 (27.12%) |
 %DSC | 86.43 ± 6.49 | 85.44 ± 7.14 |  |  |
 %JC | 76.63 ± 9.45 | 75.18 ± 10.50 |  |  |
 H (mm) | 32.50 ± 14.77 | 28.76 ± 14.68 |  |  |
 %FP | 14.13 ± 12.94 | 18.00 ± 12.35 |  |  |
 %FN-Type I | 11.84 ± 7.49 | 9.01 ± 5.55 |  |  |
 %FN-Type II | 0.59 ± 0.81 | 1.09 ± 1.79 |  |  |
Output III | ||||
 No. cases | 31 (7.03%) | 13 (11.61%) | 44 (7.96%) | 54 (9.76%) |
 %DSC | 54.26 ± 30.74 | 47.31 ± 23.93 |  |  |
 %JC | 42.87 ± 27.91 | 33.85 ± 20.02 |  |  |
 H (mm) | 72.39 ± 45.58 | 96.26 ± 46.01 |  |  |
 %FP | 53.12 ± 32.01 | 63.14 ± 25.31 |  |  |
 %FN-Type I | 6.42 ± 6.81 | 5.28 ± 12.39 |  |  |
 %FN-Type II | 0.65 ± 1.80 | 0.37 ± 1.32 |  |  |
Total | 441 | 112 | 553 | 553 |